Effect of Sitagliptin on Post-Prandial Glucagon and GLP-1 Levels in Patients With Type 1 Diabetes: Investigator-Initiated, Double-Blind, Randomized, Placebo-Controlled Trial
- 1 January 2013
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 19 (1), 19-28
- https://doi.org/10.4158/ep12100.or
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Regulation of glucagon secretion by incretinsDiabetes, Obesity and Metabolism, 2011
- Liraglutide as additional treatment for type 1 diabetesActa Endocrinologica, 2011
- Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell FunctionDiabetes Care, 2011
- Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trialDiabetes, Obesity and Metabolism, 2011
- Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitusDiabetic Medicine, 2008
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesThe New England Journal of Medicine, 2005
- Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic NephropathyJama-Journal Of The American Medical Association, 2003
- Effect of Excessive Weight Gain With Intensive Therapy of Type 1 Diabetes on Lipid Levels and Blood PressureJama-Journal Of The American Medical Association, 1998
- Hypoglycemia in the Diabetes Control and Complications TrialDiabetes, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993